Status:
NOT_YET_RECRUITING
Sustained Inflation and Chest Compression vs 3:1 C:V Ratio in Asphyxiated Newborns
Lead Sponsor:
University of Alberta
Conditions:
Cardiac Arrest
Eligibility:
All Genders
Up to 40 years
Phase:
NA
Brief Summary
Newborn infants who require cardiopulmonary resuscitation at birth receive chest compression using a 3-Compression to 1-Ventilation (3:1 C:V) ratio. However, the optimal chest compression technique du...
Eligibility Criteria
Inclusion
- Newborns with gestational age born between 28 to 43 weeks based on best available obstetrical estimate
- Newborns designated to receive full resuscitation, i.e., parental request or pre-determined decision to provide only comfort care at birth
- No known major congenital or chromosomal malformation. All newborns who meet inclusion criteria will be enrolled as the centres agreed to change their local hospital policy during the trial. The inclusion criteria are designed to be pragmatic and provide useful knowledge translation for most of the patient population in the future.
Exclusion
- \- Newborns born outside of study centers and transported to centers after delivery.
- Sex, race, and ethnicity are not part of the exclusion criteria for this trial, and as such it should represent the combined demographics of all centers involved.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2033
Estimated Enrollment :
554 Patients enrolled
Trial Details
Trial ID
NCT06577818
Start Date
January 1 2026
End Date
July 1 2033
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital
Edmonton, Canada